Bluebird Bio Inc. (NASDAQ:BLUE)

CAPS Rating: 3 out of 5

Results 1 - 13 of 13

Recs

0
Member Avatar laurao444 (< 20) Submitted: 5/19/2015 7:40:37 PM : Outperform Start Price: $173.89 BLUE Score: +2.66

They're in phase II/III trials for sickle cell and other rare blood diseases in collaboration with a larger biotech (which one Novartis? - I've forgotten since I did the research but have been following them for a while). Are on track to meet development milestones for which they'll receive payments and look like a good acquisition.

Recs

1
Member Avatar portefeuille (99.65) Submitted: 5/10/2015 4:08:21 AM : Outperform Start Price: $21.44 BLUE Score: +716.45

Now 200 BLUE shares in the #zzporte portfolio, in the green by around $38k.
https://twitter.com/portefeuillefun/status/597067869051068416.

Recs

0
Member Avatar Herbstmd (59.11) Submitted: 5/7/2015 4:00:24 PM : Outperform Start Price: $155.00 BLUE Score: +14.08

A great deal of promise inngenenetic alteration of disease states like sickle cell.

Recs

0
Member Avatar gideonstrauss (55.88) Submitted: 5/4/2015 4:51:04 PM : Outperform Start Price: $132.22 BLUE Score: +33.98

Hardcore healthy-making research sets Bluebird Bio up for a big future of SOME kind, and one of my CAPS nods to the Rulebreaker core portfolio suggestions.

Recs

0
Member Avatar MoeBruin (73.52) Submitted: 4/28/2015 12:44:34 PM : Outperform Start Price: $133.94 BLUE Score: +32.35

Cancer drugs are making breakthroughs. This stock is advanced.

Recs

0
Member Avatar stockgeek623 (< 20) Submitted: 3/28/2015 8:56:41 AM : Underperform Start Price: $117.01 BLUE Score: -49.54

I feel that biotechnology stocks always underperform at the peak market levels and try to boost their performance as trading goes on.

Recs

1
Member Avatar Gibbs721 (36.36) Submitted: 2/6/2015 10:44:32 AM : Outperform Start Price: $85.01 BLUE Score: +105.39

Early results from attempts to cure hereditary diseases using genetic treatment look promising. Continued success would be a huge breakthrough with great potential for further developments and success.

Recs

0
Member Avatar MotleyFolJohn (< 20) Submitted: 2/2/2015 11:02:22 AM : Underperform Start Price: $93.98 BLUE Score: -83.14

The Bio Sector will out perform the 2015 NASDAQ However, BlueBird Bio will under perform.
Happy Investing

Recs

1
Member Avatar sullyz0r (75.89) Submitted: 11/26/2014 5:00:33 PM : Outperform Start Price: $42.49 BLUE Score: +317.17

Big fan of gene therapy.

Recs

1
Member Avatar SkepBioInvestor (96.73) Submitted: 6/26/2014 5:21:15 PM : Outperform Start Price: $39.88 BLUE Score: +338.06

Wall St darling

Recs

1
Member Avatar loangolfer (< 20) Submitted: 1/17/2014 8:43:56 AM : Outperform Start Price: $24.26 BLUE Score: +619.59

ZZ likes it......

Recs

10
Member Avatar zzlangerhans (99.79) Submitted: 8/22/2013 1:17:56 AM : Outperform Start Price: $27.03 BLUE Score: +531.55

There's some companies I study fairly vigorously before I start nattering about them and some I don't. Bluebird falls into the latter category. There's not much I can do - I'm just one guy trying to follow 250 stocks plus I have two babies who think Dad's laptop is the greatest toy in the world. All I can say about Bluebird is that they're developing lentoviral vectors, which I believe are the vectors you use when you've given up other viral vectors for Lent. Bluebird has one trial in progress for a lentoviral gene therapy of beta thalassemia and another planned to begin in mid-2013, and they're planning to initiate a phase II/III trial of another lentoviral gene therapy for childhood cerebral adrenoleukodystrophy in late 2013.

I happen to own 40 shares of Bluebird bought at the absolute all time high of 36 on July 17, courtesy of Portefeuille. I don't mean to razz him too much; that doesn't happen very often. The stock's been in a pretty nasty declining trend since then but I have a feeling things will pick back up before long. Hopefully by then I'll have had time to brush up a little on what this company actually does.

Recs

2
Member Avatar usubanas (99.79) Submitted: 8/21/2013 2:49:52 PM : Outperform Start Price: $25.51 BLUE Score: +570.86

the future is... here

Results 1 - 13 of 13

Featured Broker Partners


Advertisement